We observed significantly higher PROX1 and α-SMA expression in patients of CRC with lymphatic invasion or lymph node metastasis compared with those of CRC without lymphatic invasion and lymph node metastasis (Table 2). The gene discussed is PROX1; the disease is colorectal carcinoma.